NCT07350954

Brief Summary

The goal of this feasibility and acceptability trial is to test whether a new brief talking therapy can be successfully provided to and is suitable for adolescents (16-18) who are seeking help from Child and Adolescent Mental Health Services (CAMHS). The main research question for the current study is: Is it feasible and acceptable to offer a brief values-based (helping young people identify what matters most to them) and imagery (using imagination to visualise positive experiences) intervention for adolescents experiencing paranoia in CAMHS? It also aims to identify preliminary clinical outcomes, particularly changes in paranoia severity as measured by the Revised Green et al., Paranoid Thoughts Scale (R-GPTS). Participants will complete an eligibility assessment and those eligible will be offered a six-session intervention. Assessment measures will be completed before, during and after the intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 24, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

January 20, 2026

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

December 8, 2025

Last Update Submit

January 10, 2026

Conditions

Keywords

ParanoiaAdolescentsChild and Adolescent Mental Health ServiceFeasibilityAcceptabilityMental Health

Outcome Measures

Primary Outcomes (4)

  • Recruitment

    Recruitment looks at how many young people can be identified, screened, and enrolled into the study. This will show whether it is practical to recruit young people with paranoia from a CAMHS waiting list. GREEN: ≥ 5 participants of target recruited AMBER: 3 to 4 of target recruited RED: ≤ 2 of target recruited.

    From screening to completion of recruitment (up to 6 months)

  • Retention

    Retention refers to how many participants stay in the study until the end. We will record how many young people complete all six therapy sessions and complete the end-of-therapy and one-month follow-up questionnaires. This shows whether young people are willing and able to stay involved in the study. GREEN: ≥5 participants providing end of therapy assessment outcome data AMBER: 3-4 participants providing end of therapy assessment outcome data RED: ≤2 participants providing end of therapy assessment outcome data

    From enrolment to one-month follow-up (up to 14 weeks)

  • Adherence

    Adherence describes how well participants follow the study schedule, including how many therapy sessions they attend. GREEN: ≥5 participants attend at least 3 sessions of therapy AMBER: 3-4 participants attend at least 3 sessions of therapy RED: ≤2 participants attend at least 3 sessions of therapy

    From first therapy session to final therapy session (up to 6 weeks).

  • Acceptability

    Acceptability looks at how young people experience the intervention and whether they find it suitable and helpful. Acceptability of the therapy will be assessed via questionnaires given to participants upon therapy completion or withdrawal and adverse effects of study participation questionnaire.

    Throughout the study, at the end of therapy, and at one month follow up (up to 14 weeks)

Secondary Outcomes (5)

  • Paranoia - Revised Green et al., Paranoid Thoughts Scale (R-GPTS) Part B

    Screening, before intervention (baseline), weekly baseline, each therapy session (weeks 1-6) and at one-month follow-up (up to 14 weeks).

  • Negative Self and Other Beliefs - The Brief Core Schema Scales (BCSS)

    Before intervention (baseline), after intervention (session 6; 6 weeks), and at one-month follow-up.

  • Mental Imagery Characteristics - The Negative Mental Imagery Questionnaire (MIQ-N)

    Before intervention (baseline), after intervention (session 6; 6 weeks), and at one-month follow-up.

  • Values - Comprehensive Assessment of Acceptance and Commitment Therapy processes for Youth (compACT-Y; Morey et al., 2024).

    Before intervention (baseline), after intervention (session 6; 6 weeks), and at one-month follow-up.

  • Functioning - Work and Social Adjustment Scale for Youth (WSAS-Y)

    Before intervention (baseline), after intervention (session 6; 6 weeks), and at one-month follow-up.

Study Arms (1)

TRUST

EXPERIMENTAL

A six-session individual psychological intervention combining values-based and mental imagery techniques for adolescents experiencing paranoia.

Behavioral: TRUST

Interventions

TRUSTBEHAVIORAL

Participants will receive TRUST, a six-session individual psychological intervention designed for adolescents who experience frequent or distressing suspicious thoughts about others. The intervention includes values-based work to identify what matters most to the young person, and mental imagery techniques aimed at modifying distressing beliefs about the self and others. Session 1: Assessment, Formulation and Psychoeducation Session 2: Values and value based goals Session 3-5: Harnessing imagery to pursue values and imagery focussed strategies to change negative beliefs about self and others Session 6: Bringing it all together and review.

TRUST

Eligibility Criteria

Age16 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged 16-18
  • Seeking help from a Child and Adolescent Mental Health Service (CAMHS)
  • A score ≥ 11 on the R-GPTS (Scale B)
  • Sufficient understanding of English
  • Capacity to consent, as assessed during the initial interview
  • Wanting support with paranoia
  • Low- moderate mental health risks (emotional difficulties that impact functioning, but no immediate risk to safety e.g., no suicidal intent).

You may not qualify if:

  • Severe comorbid diagnoses apparent at the initial assessment (e.g., a primary alcohol or substance dependence issue measured using standardised assessments)
  • The presence of a developmental disability or cognitive impairment that would interfere with participation.
  • Concurrent participation in another psychological therapy
  • High levels of current risk (e.g., significant and immediate concerns about the young person's safety, such as suicidal intent).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Westminster's Child and Adolescent Mental Health Service

London, W9 2NW, United Kingdom

RECRUITING

Related Publications (10)

  • Morey A, Samuel V, Lewis M, Williams M. Validation of the comprehensive assessment of acceptance and commitment therapy processes for youth: The CompACT-Y. JCPP Adv. 2024 Aug 11;5(2):e12271. doi: 10.1002/jcv2.12271. eCollection 2025 Jun.

    PMID: 40519958BACKGROUND
  • Parker A, Kingston J. Evaluating a values-based intervention for adolescence with high nonclinical paranoia: A schools-based randomised control trial. Cogn Ther Res. 2022;46:620-8. doi: 10.1007/s10608-021-10278-6

    BACKGROUND
  • Yung AR, McGorry PD, Francey SM, Nelson B, Baker K, Phillips LJ, Berger G, Amminger GP. PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust. 2007 Oct 1;187(S7):S43-6. doi: 10.5694/j.1326-5377.2007.tb01336.x.

    PMID: 17908025BACKGROUND
  • Kingston J, Ellett L. Self-affirmation and nonclinical paranoia. J Behav Ther Exp Psychiatry. 2014 Dec;45(4):502-5. doi: 10.1016/j.jbtep.2014.07.004. Epub 2014 Jul 22.

    PMID: 25090449BACKGROUND
  • Garety PA, Freeman D. The past and future of delusions research: from the inexplicable to the treatable. Br J Psychiatry. 2013 Nov;203(5):327-33. doi: 10.1192/bjp.bp.113.126953.

    PMID: 24187067BACKGROUND
  • van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry. 2016 Jun;15(2):118-24. doi: 10.1002/wps.20310.

    PMID: 27265696BACKGROUND
  • Oaie FE, Bower JL, Steel C. The development of the Negative Mental Imagery Questionnaire (MIQ-N). Behav Cogn Psychother. 2025 Mar;53(1):17-29. doi: 10.1017/S1352465824000304. Epub 2024 Oct 18.

    PMID: 39421888BACKGROUND
  • Jassi A, Lenhard F, Krebs G, Gumpert M, Jolstedt M, Andren P, Nord M, Aspvall K, Wahlund T, Volz C, Mataix-Cols D. The Work and Social Adjustment Scale, Youth and Parent Versions: Psychometric Evaluation of a Brief Measure of Functional Impairment in Young People. Child Psychiatry Hum Dev. 2020 Jun;51(3):453-460. doi: 10.1007/s10578-020-00956-z.

    PMID: 32006302BACKGROUND
  • Freeman D, Loe BS, Kingdon D, Startup H, Molodynski A, Rosebrock L, Brown P, Sheaves B, Waite F, Bird JC. The revised Green et al., Paranoid Thoughts Scale (R-GPTS): psychometric properties, severity ranges, and clinical cut-offs. Psychol Med. 2021 Jan;51(2):244-253. doi: 10.1017/S0033291719003155. Epub 2019 Nov 20.

    PMID: 31744588BACKGROUND
  • Taylor CDJ, Bee PE, Kelly J, Emsley R, Haddock G. iMAgery focused psychological therapy for persecutory delusions in PSychosis (iMAPS): a multiple baseline experimental case series. Behav Cogn Psychother. 2020 Sep;48(5):530-545. doi: 10.1017/S1352465820000168. Epub 2020 Apr 8.

    PMID: 32264985BACKGROUND

MeSH Terms

Conditions

Paranoid DisordersPsychological Well-Being

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersPersonal SatisfactionBehavior

Central Study Contacts

Jessica Kingston, DClinPsy PhD

CONTACT

Christopher Taylor, DClinPsy PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief Investigator

Study Record Dates

First Submitted

December 8, 2025

First Posted

January 20, 2026

Study Start

October 24, 2025

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

January 20, 2026

Record last verified: 2025-12

Locations